String Metaverse Ltd plans to raise funds through a rights issue, with its board meeting on November 7th, 2025, to approve the fundraising and review financial results. The company aims to strengthen capital and meet regulatory requirements, building on previous successful capital raises.
                                        
                        
	String Metaverse Ltd, formerly known as Bio Green Papers Ltd, is set to consider raising funds through a rights issue, as announced ahead of a crucial board meeting scheduled for November 7th, 2025. This strategic move aims to bolster the company's capital base and comply with Minimum Public Shareholding norms mandated for listed entities. Alongside the fundraising proposal, the meeting will review the company’s Q2 and H1 FY2026 financial results and discuss a new employee stock option scheme.
	 
	The rights issue initiative reflects the company’s commitment to strengthening its financial position and enhancing shareholder value amid its transition into the Web3 technology space. String Metaverse has garnered robust investor interest in its previous capital raises, with its rights issue oversubscribed and raising upwards of ₹49 crore last year. The company’s evolving focus on innovation and shareholder engagement positions it attractively in a competitive sector.
	 
	Notable updates:
	- 
		Board meeting scheduled for November 7th, 2025, to approve rights issue and financial results.
 
	- 
		Rights issue planned to raise additional capital and meet public shareholding norms.
 
	- 
		Discussion on “String Metaverse Employee Stock Option Scheme 2025 (Series II).”
 
	- 
		Review and approval of draft notice for shareholder approval via postal ballot.
 
	- 
		Previous rights issue raised ₹49.25 crore with oversubscription, demonstrating strong market confidence.
 
	String Metaverse’s strategic capital raising and governance actions underscore its forward-looking corporate approach in the growing Web3 domain.
	 
	Sources: Reuters, ScanX Trade, Equity Bulls, Tijori Finance, Trade Brains.